Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma: A Study of 59 Cases
Danielle Canioni, Bénédicte Deau-Fischer, Pierre Taupin et al. · 2009
Read Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma: A Study of 59 Cases by Danielle Canioni, Bénédicte Deau-Fischer, Pierre Taupin et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006341.txt.
Description
Most classical Hodgkin lymphoma patients are cured, but a significant minority fail first treatment. Danielle Canioni and colleagues tested new immunohistochemical markers in fifty-nine refractory cases in a 2009 PLOS ONE paper. No consensus exists on biological markers that add value beyond usual clinical parameters.
Stains that reveal proteins in tumor tissue were checked for prognostic significance. A reliable marker could flag high-risk patients for stronger or experimental therapy early. It could also spare low-risk patients excess toxicity. The study weighs candidate markers in the hardest cases. More work will be needed to prove which marks hold up in new groups of cases.
Catalog record
| CREATOR | Danielle Canioni, Bénédicte Deau-Fischer, Pierre Taupin et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006341